Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Itraconazole on LY3200882 PK
NCT03792139Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2019
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ly3200882 in cancer, pancreatic cancer (PC) and glioma (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Maximum Drug Concentration of LY3200882 and Area Under the Concentration Curve of LY3200882. Started Jan 2019; status: completed.
02
Drugs
ly3200882
03
Conditions
cancerpancreatic cancer (PC)glioma
Beyond the preview
Go deeper on NCT03792139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792139.